Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendritic Mesoporous UiO-66 as Nanoreactors for Dual-Mode Detection of the Rabies Virus Nucleoprotein Gene.

Analytical chemistry·2025
Same author

Microenvironment-Responsive Cu-MOF Nanoplatform Activates Disulfiram for Synergistic Bacterial Killing and Enhanced Infected Wound Healing.

Advanced healthcare materials·2025
Same author

Magnetic bead-assisted one-pot RCA-activated CRISPR/Cas12a electrochemiluminescence biosensor for the detection of citrus Huanglongbing pathogen.

Biosensors & bioelectronics·2025
Same author

MnOx nanoflower-based ultrasound-responsive drug delivery for sonodynamic therapy of wound infections.

Ultrasonics sonochemistry·2025
Same author

Chitosan-based double-network hydrogel with synergistic photothermal/nitric oxide therapy for methicillin-resistance Staphylococcus aureus infected wound healing.

Journal of colloid and interface science·2025
Same author

Biomimetic Copper-Based Nanoplatform for Enhanced Tumor Targeting and Effective Melanoma Therapy.

ACS applied bio materials·2025

Related Experiment Video

Updated: Aug 17, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K

Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics.

Zhaoyu Ma1, Heyou Han2, Yanli Zhao3

  • 1The State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, College of Science, Huazhong Agricultural University, Wuhan 430070, PR China; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.

Biomaterials
|December 13, 2022
PubMed
Summary

Targeting cancer cell mitochondria with nanosystems induces dysfunction, offering a promising new avenue for precise cancer therapy. This approach disrupts key cellular processes, paving the way for advanced treatments.

Keywords:
Cancer therapeuticsMitochondria targetingMitochondrial dysfunctionNanosystemsTumor treatment

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

421
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Related Experiment Videos

Last Updated: Aug 17, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

421
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Biology

Background:

  • Mitochondria are crucial regulators of cancer cell proliferation and apoptosis.
  • Targeting mitochondrial dysfunction in cancer is an emerging therapeutic strategy.
  • Nanosystems offer precise delivery for inducing mitochondrial dysfunction in tumors.

Purpose of the Study:

  • To review strategies for constructing mitochondria-targeted nanosystems.
  • To summarize recent advances in using mitochondrial dysfunction for cancer therapy.
  • To discuss challenges and future directions in this field.

Main Methods:

  • Review of literature on mitochondria-targeted nanosystems.
  • Analysis of mechanisms of mitochondrial dysfunction induction.
  • Highlighting recent research progress in precise tumor therapeutics.

Main Results:

  • Nanosystems can induce mitochondrial dysfunction through various mechanisms (e.g., ATP reduction, redox imbalance, depolarization).
  • These strategies enable precise tumor therapy by exploiting cancer cell vulnerabilities.
  • Understanding these mechanisms is key to clinical translation.

Conclusions:

  • Mitochondria-targeted nanosystems represent a promising approach for precise cancer treatment.
  • Further research is needed to overcome challenges and accelerate clinical application.
  • This field holds potential for treating various human diseases beyond cancer.